David L. Lacey

CIK 1734422 · last filed 2026-05-15

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.69M

Companies

4

Total Filings

19

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NRIX Director $16.95 $0 6 2026-05-15
RCUS Director 70,952 $23.80 $1.69M $0 7 2025-06-12
Atreca, Inc. (BCEL) Delisted Director $0.15 $0 4 2023-06-15
Unity Biotechnology, Inc. (UBX) Delisted Director $0.20 $0 2 2020-06-22

Recent Filings · Page 2 of 2

19 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-06-10 Atreca, Inc. (BCEL) Delisted Grant (A) $0 EDGAR
2022-05-06 NRIX Grant (A) $0 EDGAR
2021-06-11 Atreca, Inc. (BCEL) Delisted Grant (A) $0 EDGAR
2021-06-07 RCUS Grant (A) +3,000 $0 EDGAR
2021-05-24 NRIX Grant (A) $0 EDGAR
2020-06-22 Unity Biotechnology, Inc. (UBX) Delisted Grant (A) $0 EDGAR
2020-06-15 Atreca, Inc. (BCEL) Delisted Grant (A) $0 EDGAR
2020-05-26 RCUS Grant (A) $0 EDGAR
2019-06-24 Unity Biotechnology, Inc. (UBX) Delisted Grant (A) $0 EDGAR
Showing 1119 of 19
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.